Loading clinical trials...
Loading clinical trials...
Evaluation of Predictive Biomarkers in de Novo Multiple Myeloma on the Onset of Venous Thromboembolism, Its Impact on Clinical Outcome and Thromboprophylaxis (VESICOM)
Conditions
Interventions
Blood samples
Locations
2
France
Hospices Civils de Lyon
Lyon, France
CHU de Saint-Etienne
Saint-Etienne, France
Start Date
May 20, 2022
Primary Completion Date
October 30, 2025
Completion Date
October 30, 2027
Last Updated
April 9, 2025
NCT07423390
NCT07435597
NCT07218874
NCT06313203
NCT06510010
NCT04724499
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions